Last reviewed · How we verify

An Open-Label, Randomized, Parallel-Group Drug-Drug Interaction Study to Assess the Effect of Multiple Doses of Itraconazole or Gemfibrozil on the Pharmacokinetics of a Single Dose of JNJ-56021927 in Healthy Male Subjects

NCT02230033 Phase 1 COMPLETED

The purpose of this study is to assess the effect of multiple doses of itraconazole or gemfibrozil on the pharmacokinetics (the study of the way a drug enters and leaves the blood and tissues over time) of JNJ-56021927 and its metabolites (JNJ 56142060 and JNJ-56142021) in healthy male participants.

Details

Lead sponsorAragon Pharmaceuticals, Inc.
PhasePhase 1
StatusCOMPLETED
Enrolment45
Start date2014-09
Completion2014-12

Conditions

Interventions

Primary outcomes

Countries

United States